APA (7th ed.) Citation

Zhang, Q., Zhao, Y., Ma, H., Wang, D., Cui, L., Li, W., . . . Zhang, R. (2022). A study of ruxolitinib response–based stratified treatment for pediatric hemophagocytic lymphohistiocytosis. Blood, 139(24), 3493-3504. https://doi.org/10.1182/blood.2021014860

Chicago Style (17th ed.) Citation

Zhang, Qing, et al. "A Study of Ruxolitinib Response–based Stratified Treatment for Pediatric Hemophagocytic Lymphohistiocytosis." Blood 139, no. 24 (2022): 3493-3504. https://doi.org/10.1182/blood.2021014860.

MLA (9th ed.) Citation

Zhang, Qing, et al. "A Study of Ruxolitinib Response–based Stratified Treatment for Pediatric Hemophagocytic Lymphohistiocytosis." Blood, vol. 139, no. 24, 2022, pp. 3493-3504, https://doi.org/10.1182/blood.2021014860.